Gilead’s antiviral drug remdesivir has been authorized by US regulators for emergency use on coronavirus patients, President Donald Trump announced Friday.
US medical officials have announced evidence from a trial that remdesivir helped patients with serious cases of COVID-19 recover faster.
Trump has been a vocal supporter of remdesivir as a possible way to bring the novel coronavirus pandemic under control. Nearly 65,000 Americans have died in the global crisis.
READ ALSO: Edo accuses Oshiomhole of ‘spitting on the graves’ of those who died from COVID-19
Vanguard had earlier reported that the coronavirus patients on the antiviral remdesivir recovered more than 30 per cent faster than those on a placebo, the results of a major clinical trial showed Wednesday as a top US scientist hailed the drug’s “clear-cut” benefit.
It represents the first time any medication has been shown to improve outcomes against the coronavirus illness, which has claimed more than 200,000 lives globally and brought the world economy to a grinding halt.
Anthony Fauci, who oversaw the investigation, told reporters at the White House: “The data shows that remdesivir has a clear-cut, significant, positive effect in diminishing the time to recovery.”
He added that the trial was proof “that a drug can block this virus,” and compared the finding to the arrival of the first antiretrovirals that worked against HIV in the 1980s, albeit with modest success at first.
READ ALSO: Atiku’s company sacks 46 staff on Workers’ Day
Are you an artiste? Do you want your music to go viral and reach a large number of audience? Promote your music and Submit your story on Ujuayalogusblog.com by clicking here. For Advert Inquiries Tel/+44(0)7590363984
For More: Subscribe to Ujuayalogusblog.com
No comments:
Post a Comment